NGM BIOPHARMACEUTICALS INC (NGM) Stock Income Statement
USA - NASDAQ:NGM - US62921N1054 - Common Stock
1.54 USD
-0.02 (-1.28%)
1.55 USD
+0.01 (+0.65%)
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.42M | 55.30M | 77.90M | 87.40M | 103.50M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 155.88M | 221.60M | 198.60M | 191.20M | 152.90M | |||
| Research and Development | 118.04M | 181.10M | 161.70M | 164.00M | 129.30M | |||
| Selling, General, and Administrative Expenses | 37.84M | 40.50M | 36.90M | 27.20M | 23.60M | |||
| Operating Income | -151.46M | -166.20M | -120.70M | -103.80M | -49.30M | |||
| Interest Income/Expense | 9.32M | 3.70M | 400.00K | 1.90M | 6.70M | |||
| Other Income/Expense | -234.00K | -100.00K | -100.00K | -600.00K | -100.00K | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -142.38M | -162.70M | -120.30M | -102.50M | -42.80M | |||
| Income Tax | null | null | null | null | 0 | |||
| Net Income | -142.38M | -162.70M | -120.30M | -102.50M | -42.80M | |||
| EBITDA | -149.24M | -162.16M | -114.61M | -97.24M | -41.69M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.72584 | -2.03 | -1.56 | -1.5 | -0.64 | |||
| Non GAAP EPS | -1.7199999999999998 | -2.05 | -1.56 | -1.49 | -1.75 | |||
| Statistics | ||||||||
| Profit Margin | -3223.34% | -294.21% | -154.43% | -117.28% | -41.35% | |||
| Operating Profit Margin | -3429.09% | -300.54% | -154.94% | -118.76% | -47.63% | |||
All data in USD